Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus reuteri for Oral Mucositis in Head and Neck Cancer Radiotherapy
NCT06285591Phase 2Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2024
- Primary completion
- Jan 2025
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of lactobacillus reuteri in oral mucositis (OM), sponsored by West China Hospital of Sichuan University. Started Mar 2024; status: completed.
02
Drugs
lactobacillus reuteri
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT06285591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06285591.